Jeddah, Saudi Arabia

Mohammed Zainy Mutawakil

This inventor holds 1 USPTO granted patent. Top assignee: King Abdulaziz University. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mohammed Zainy Mutawakil. Retrieved from https://idiyas.com/inventor/mohammed-zainy-mutawakil

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mohammed Zainy Mutawakil: Innovator in Cancer Treatment

Introduction

Mohammed Zainy Mutawakil is a notable inventor based in Jeddah, Saudi Arabia. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His innovative work has the potential to impact the lives of many patients battling this disease.

Latest Patents

Mutawakil holds a patent for a pharmaceutical composition aimed at treating cancer. This composition features an anticancer compound known as isopicrinine, which is isolated from a plant. The patent also includes a method for treating cancer using this pharmaceutical composition. Additionally, it discloses a method for extracting isopicrinine, showcasing his commitment to advancing medical science.

Career Highlights

He is affiliated with King Abdulaziz University, where he contributes to research and development in the pharmaceutical field. His work at the university allows him to collaborate with other experts and further his research endeavors.

Collaborations

Some of his notable coworkers include Jamal Sabir M Sabir and Abdullah Yousef Obaid. Their collaboration enhances the research environment and fosters innovation in their projects.

Conclusion

Mohammed Zainy Mutawakil is a dedicated inventor whose work in cancer treatment exemplifies the importance of innovation in medicine. His contributions are paving the way for new therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…